See also this year's filing and all EDGAR filings for this company.
PDF Report 0001557746_2022_Aclaris_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001557746, Aclaris Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 205,032,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,048,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,335,000 |
| 3 | remainder_Assets | 37,796,000 |
| 4 | LiabilitiesCurrent | 22,931,000 |
| 5 | LiabilitiesNoncurrent | 2,172,000 |
| 6 | remainder_Liabilities | 28,767,000 |
| 7 | CostOfGoodsAndServicesSold | 4,808,623 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,491,102 |
| 9 | ResearchAndDevelopmentExpense | 44,493,446 |
| 10 | remainder_Expenses | 17,380,852 |
| 11 | remainder_Revenues | 6,677,009 |
| 12 | remainder_NetIncome | -841,241 |
| 13 | remainder_ComprehensiveNetIncome | -134,166 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 251,211,000 |
| 1 | Liabilities | 53,870,000 |
| 2 | Expenses | 91,174,023 |
| 3 | Revenues | 6,677,009 |
| 4 | StockholdersEquity | 197,341,000 |
| 5 | NetIncome | -85,338,255 |
| 6 | ComprehensiveNetIncome | -85,405,338 |
| 7 | BaseVar | 201,953,720 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.26 |
| 9 | EconomicCapitalRatio | 3.20 |
Edgar->Model Mapping
Feature Distribution
Change over Time
